Abstract
Background
An intense increase in pre-diabetes has taken place among the worldwide population each year. The purpose of this study was to assess the diagnostic validity of the American Diabetes Association (ADA) screening questionnaire for identifying pre-diabetes in the Iranian rural population.
Methods
This study was conducted in Ahar County, East Azarbaijan, Iran. The participants (n = 440) were randomly recruited via trained community health care workers. The ADA questionnaire including six items (age, gender, having family members with diabetes, obesity, hypertension, and physical activity) is the screening tool used to identify people at high risk for developing type 2 diabetes. The World Health Organization (WHO) forward/backward translation protocol was used for translating the assessment tool. The diagnosis of pre-diabetes was defined based on the fasting blood glucose (FBG, as a gold standard) cut-points of 100 mg/dl to 125 mg/dl. We assessed the criterion validity and diagnosis characteristics of the ADA questionnaire in the diagnosis of pre-diabetes using the measures of sensitivity, specificity, and receiver operating characteristics (ROC) curves. In addition, the optimal cut-point of the ADA questionnaire for the diagnosis of pre-diabetes was computed using Youden’s index.
Results
A total of 440 adults ages 30–65 years (Mage = 48.8 years, SDage = 11.2 years) were included in the study. Around half of the participants were women (50%), illiterate (51.4%), and married (85.2). In the pre-diabetes diagnosis scale, the present cut-point yielded a sensitivity of 98.7 (95% CI:96.6–99.6), specificity of 53.1 (95% CI: 44.6–61.5), positive predictive value (PPV) of 81.4 (95% CI:77–85.3), positive predictive value (NPV) of 95.0 (95% CI:87.7–98.6), and accuracy of 83.9 (95% CI:81.4–89.2) with an area under curve (AUC) of 0.84 (95% CI: 0.80 − 0.89).
Conclusions
The Persian version of the ADA questionnaire had good sensitivity and fair specificity for pre-diabetes diagnosis among rural adults at high risk for developing type 2 diabetes. The study provided evidence for the ADA questionnaire as a valid and reliable tool for identifying pre-diabetes in a rural area. Identifying rural residents in the early stage of developing diabetes with a simple and accurate instrument without the need for a FBG test contributes to controlling the disease in areas with limited access to health services.
Trial registration
The study is not a trial; the registration number is not applicable.
Similar content being viewed by others
Data availability
The data collection tools and datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Abbreviations
- CVD:
-
cardiovascular diseases
- ADA:
-
American diabetes association
- WHO:
-
World Health Organization
- FBG:
-
Fasting blood glucose
- NHANES:
-
National Health and Nutrition Examination Survey
- BMI:
-
Body Mass Index
- NPV:
-
Negative Predictive Value
- PPV:
-
Positive Predictive Value
References
Fox CS, Coady S, Sorlie PD, D’Agostino RB, Pencina MJ, Vasan RS, Meigs JB, Levy D, Savage PJ. Increasing cardiovascular disease burden due to diabetes mellitus. The Framingham Heart Study. Circulation. 2007;115:1544–50.
Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332:73–8.
Noshad S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes care in Iran: Where we stand and where we are headed. Ann Glob Health. 2015;81:839–50.
Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics. 2010;8:29.
Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B. Impaired fasting glucose and impaired glucose tolerance. Implications Care. 2007;30:753–9.
Control CfD, Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2010. Avalable; www.diasentry.com/LearningCenter/DiabetesInformation/CDC-DiabtesFacts2011.pdf.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. 2004;27:1047–1053.
Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, Safaie A, Forouzanfar M, Gregg EW. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran. National Survey of risk factors for non-communicable diseases of Iran. Diabetes Care. 2008;31:96–8.
Latifi SM, Karandish M, Shahbazian H, Hardani Pasand L. Incidence of prediabetes and type 2 diabetes among people aged over 20 years in Ahvaz: A 5-year perspective study (2009–2014). J Diabetes Res. 2016;2016:4908647.
Alouki K, Delisle H, Bermúdez-Tamayo C, Johri M. Lifestyle interventions to prevent type 2 diabetes: A systematic review of economic evaluation studies. J Diabetes Res. 2016;2016:2159890.
Bagust A, Hopkinson PK, Maslove L, Currie CJ. The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060. Diabet Med. 2002;19:1–5.
Najafipour H, Sanjari M, Shokoohi M, Haghdoost A-A, Afshari M, Shadkam M, Etemad K, Mirzazade A. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes and its predictors in general population aged 15 to 75 years: A community-based study (KERCADRS) in southeastern Iran. J Diabetes. 2015;7:613–21.
Bang H, Edwards AM, Bomback AS, Ballantyne CM, Brillon D, Callahan MA, Teutsch SM, Mushlin AI, Kern LM. Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med. 2009;151:775–83.
Glümer C, Carstensen B, Sandbæk A, Lauritzen T, Jørgensen T, Borch-Johnsen K. A Danish diabetes risk score for targeted screening. Diabetes Care. 2004;27:727–33.
Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diabetes Vasc Dis Res. 2005;2:67–72.
Zhang L, Zhang Z, Zhang Y, Hu G, Chen L. Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among US adults by gender and race: NHANES 1999–2010. PLoS One. 2014;9:e97865.
Guasch-Ferré M, Bulló M, Costa B, Martinez-Gonzalez MA, Ibarrola-Jurado N, Estruch R, Barrio F, Salas-Salvadó J, Investigators P-P. A risk score to predict type 2 diabetes mellitus in an elderly Spanish Mediterranean population at high cardiovascular risk. PLoS One. 2012;7:e33437.
Chuma J, Gilson L, Molyneux C. Treatment-seeking behaviour, cost burdens and coping strategies among rural and urban households in Coastal Kenya: an equity analysis. Trop Med Int Health. 2007;12:673–86.
Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care. 1995;18:382–7.
Heikes KE, Eddy DM, Arondekar B, Schlessinger L. Diabetes risk calculator. A simple tool for detecting undiagnosed diabetes and pre-diabetes 2008;31:1040–1045.
Engelgau MM, Narayan K, Herman WH. Screening for type 2 diabetes. Diabetes Care. 2000;23:1563–80.
Burden ML, Burden AC. The American Diabetes Association Screening Questionnaire for Diabetes: Is it worthwhile in the U.K. Diabetes Care. 1994;17:97–7.
Shamizadeh T, Jahangiry L, Sarbakhsh P, Ponnet K. Social cognitive theory-based intervention to promote physical activity among prediabetic rural people: a cluster randomized controlled trial. Trials. 2019;20(1):98.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–71.
Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign: Human Kinetics Books; 1988.
Lohman T, Roche A, Martorell R. Antropometric Standardization Reference Manual Human Kinetics Book. Human Kinetics, Champaign;1988, 4.
AD Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:81–90.
Altman DG, Bland JM. Diagnostic tests. 1: Sensitivity and specificity. BMJ. 1994;308:1552.
Robinson CA, Agarwal G, Nerenberg K. Validating the CANRISK prognostic model for assessing diabetes risk in Canada’s multi-ethnic population. Chronic Diseases Injuries in Canada. 2011;32:19–31.
Long J, Rozo-Rivera A, Akers T, VanGeest JB, Bairan A, Fogarty KJ, Sowell R. Validating the utility of the Spanish version of the American Diabetes Association Risk Test. Clin Nurs Res. 2006;15:107–18.
Ricci-Cabello I, Ruiz-Perez I, Rojas-García A, Pastor G, Gonçalves DC. Improving diabetes care in rural areas: A systematic review and meta-analysis of quality improvement interventions in OECD countries. PLoS One. 2013;8:e84464.
Alfaqeeh G, Cook EJ, Randhawa G, Ali N. Access and utilisation of primary health care services comparing urban and rural areas of Riyadh Providence, Kingdom of Saudi Arabia. BMC Health Serv Res. 2017;17:106.
Acknowledgements
We are grateful to Tabriz University of Medical Sciences for providing facilities for the study.
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethics approval and consent to participate
Informed consent was obtained from all participants. The study received ethical approval from the Ethics Committee of Tabriz University of Medical Sciences (NO: IR. TBZMED. REC. 1395. 13).
Consent for publication
The authors have agreed on the content of the manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jahangiry, L., Shamizadeh, T., Sarbakhsh, P. et al. Diagnostic validity of the pre-diabetes scale among at-risk rural Iranian adults for screening for pre-diabetes. J Diabetes Metab Disord 19, 823–828 (2020). https://doi.org/10.1007/s40200-020-00568-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-020-00568-3